Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details

Size: px
Start display at page:

Download "Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details"

Transcription

1 Provision of Near-Patient Testing Service Service Level Agreement Contents: 1. Financial Details 2. Service Aims 3. Criteria 4. Ongoing Measurement & Evaluation 5. Accreditation 1. Background Originally commissioned in 2004, the Near Patient Testing was aimed at monitoring those patients currently being prescribed a range of drugs particularly focussed in the field of Rheumatology following an agreed shared care plan with secondary care as evidence shows the incidence of side effects can be reduced if shared care plan monitoring is carried out in a well organised way, close to the patients home 1. In the guidelines 2, the British Society for Rheumatology (2008) discussed various DMARD s, all of which are included in this service (excluding Hydroxychloroquine) due to minimal use and minimal monitoring respectively. 2. Financial Details This agreement is to cover the 36 months commencing 1 April Each practice contracted to provide this service will receive a monthly payment in line with prior year activity. Payment adjustments will be made quarterly based on actual activity levels calculated as 25% of the annual contract value detailed below times the number of patients in each quarter. For example 5 patients on Leflunomide (only) in Q1 will generate a payment of 5 (patients) x 10 (i.e. a quarter of the 40pa payment). Where a patient is receiving shared care across multiple drugs; only one monitoring payment at the highest level relevant to those drugs will be made. For example, if a patient is on Azathioprine (level 3) and Denosumab (level 1) payment will be at level three. 1 British Society for Rheumatology (2008) BSR/BHPR Guideline for Disease-modifying Anti-rheumatic Drug (DMARD) Therapy in Consultation with the British Association of Dermatologists, Oxford University Press 2 British Society for Rheumatology (2008) BSR/BHPR Guideline for Disease-modifying Anti-rheumatic Drug (DMARD) Therapy in Consultation with the British Association of Dermatologists, Oxford University Press

2 Shared Care Drugs Monitoring Intensity Levels Payment per patient Per Annum Azathioprine Ciclosporin Mercaptopurine Dronedarone Methotrexate Year 1 Denosumab Sodium Aurothiomalate Dronedarone Sulfasalazine Leflunomide Mycophenolate Penicillamine Sulfasalazine Level One Level One Level One - Year 2 onwards Level One - Year 2 Level Two Level Two Level Two Level Two Year 1 Practices will be requested to complete quarterly activity returns in 2016/17 which the CCG will reconcile against activity reports run centrally from TPP SystmOne and equivalent clinical systems. Through discussion with practices differences will be identified and agreed in order to eliminate future differences throughout 2016/17. Quarterly payment adjustments will be made based on agreed actual activity levels. From 2017/18 onwards it is envisaged that the CCG will run central searches in order to make quarterly payment adjustments based on actual activity, following the alignment of activity reporting within 2016/17. In signing up to this service the practice agrees to recording patient activity using the read codes above, and agrees for the CCG to reconcile quarterly activity returns to central reports run based on these read codes, for payment and audit purposes. Practices will be paid where they have accepted responsibility for monitoring patients according to locally agreed shared care guidance or a care plan agreed with secondary care for that patient. The CCG reserves the right to make changes to, add, amend or cancel this service with three months given notice. 3. Service Aims The treatment of several diseases within the fields of medicine is increasingly reliant on drugs that, while clinically effective, need regular blood monitoring. This is due to the potentially serious side-effects that these drugs can occasionally cause. It has been shown that the incidence of side-effects can be reduced significantly if this monitoring is carried out in a well-organised way, close to the patient s home. The near patient testing service is designed to be one in which: (i) Therapy should only be started for recognised indications for specified lengths of time (ii) Maintenance of patients first stabilised in the secondary care setting should be properly controlled (iii) The service to the patient is convenient (iv) The need for continuation of therapy is reviewed regularly

3 (v) The therapy is discontinued when appropriate (vi) The use of resources by the National Health Service is efficient. 4. Criteria All practices are expected to provide essential services as well as additional services they are individually contracted to provide to all their patients. This enhanced service specification outlines the more specialised services to be provided. The specification of this service is designed to cover the enhanced aspects of clinical care of the patient all of which are beyond the scope of essential services. No part of the specification by commission, omission or implication defines or redefines essential or additional services. Different amber drugs require different levels of monitoring. There are three levels of monitoring intensity levels being proposed within the proposed contract: high intensity blood monitoring required. A shared care drug monitoring service including frequent blood testing, in respect of the following drugs: Drug Azathioprine Ciclosporin Mercaptopurine Methotrexate Dronedarone (Year One only) Indication Arrhythmias Level Two medium/low intensity blood monitoring. Monitoring including blood testing, in respect of the following drugs: Drug Leflunomide Mycophenolate Penicillamine Sulfasalazine (Year One only) Indication Level One routine monitoring only, in respect of the following: Drug Sulfasalazine (Year Two only) Denosumab Sodium Aurothiomalate Dronedarone (Year Two onwards) Indication Osteoporosis Arrhythmias This service will fund: (i) A shared care drug monitoring service in respect of the following specified drugs: Azathioprine Ciclosporin Leflunomide Mercaptopurine Mycophenolate Denosumab Dronedarone Penicillamine

4 Sulfasalazine Methotrexate Sodium Aurothiomalate In accordance with local shared care agreements (SCAs) or individually agreed care plans. For the drugs included in the service, the following monitoring requirements are specified in the SCAs. GP Responsibilities: 1 Reply to the request for shared care as soon as practicable. 2 Prescribe the drug at the dose recommended. 3 Carry out monitoring according to the guideline recommendations. 4 Ensure the patient is aware of any treatment change and that where held, the monitoring booklet is up to date. 5 Report to and seek advice from the specialist on any aspect of patient care that is of concern and may affect treatment. 6 Refer patient to specialist if his or her condition deteriorates. 7 Stop treatment on the advice of the specialist or immediately if an urgent need to stop treatment arises. 8 Report adverse events to the specialist team and to the MHRA via the yellow card scheme. Monitoring should be as per local shared care agreements found at the following links: BCAP Formulary (RUH): Care_DMARD_monitoring_guidelines-30th-Sept-2015.pdf 3Ts formulary (GWH): See Rheumatology section at bottom of page. ICID formulary (SFT): There are currently no shared care agreements available, so please use those available from 3Ts or BCAP formulary. The general responsibilities for ALL of the drugs are as follows: (ii) A register. Practices should be able to produce and maintain an up-to-date register of all shared care drug monitoring service patients, indicating: patient name date of birth indication and duration of treatment date practice accepted responsibility for monitoring last hospital appointment. (iii) Call and recall. To ensure that systematic call and recall of patients on this register is taking place. (iv) Continuing information for patients. To ensure that all patients, (and/or their carers and support staff when appropriate), are informed of how to access appropriate and relevant information. (v) Professional links. To work together with other professionals when appropriate. Any health care professionals involved in the care of patients in the programme should be appropriately trained.

5 (vi) Referral policies. Where appropriate to refer patients promptly to other necessary services and to the relevant support agencies using locally agreed guidelines where these exist. (vii) Record keeping. To maintain adequate records of the service provided, incorporating all known information relating to any significant events e.g. hospital admissions, death of which the practice has been notified. (viii) Training. Each practice must ensure that all staff involved in providing any aspect of care under this scheme has the necessary training and skills to do so. Staff are expected to keep up-to-date with current evidence and guidance. 5. Ongoing Measurement & Evaluation Untoward events It is a condition of participation in this service that practitioners will give notification, in addition to their statutory obligations, within 72 hours of the information becoming known to him/her, to the CCG clinical governance lead of all emergency admissions or deaths of any patient covered under this service, where such admission or death is or may be due to usage of the drug(s) in question or attributable to the relevant underlying medical condition. Annual review All practices involved in the scheme should perform an annual review, which could include: (a) Brief details as to arrangements for each of the aspects highlighted in the service (b) Details of any computer-assisted decision-making equipment used and arrangements for internal and external quality assurance (c) Details of any near-patient testing equipment used and arrangements for internal and external quality assurance (d) Details of training and education relevant to the drug monitoring service (e) Details of the standards used for the control of the relevant condition (f) Assurance that any staff member responsible for prescribing has the necessary skills to prescribe safely. Clinical System Searches Year 1 practice will continue to submit manual returns for this service. These will be reconciled on a quarterly basis with information from the central reporting unit for TPP SystmOne and equivalent searches for other clinical systems. The central reporting searches will be shared across all practices to allow identification of any anomalies and unified agreed search criteria for year 2. Year 2 and 3 Data will be collated using the central reporting unit for TPP SystmOne and equivalent searches for other clinical systems. No reporting required from individual practices. Note, the central reporting searches to allow identification of medication prescribed by a secondary care provider (e.g. hospital prescribed medication). Instructions on how to record these drugs are available here: 6. Accreditation

6 Those doctors who have previously provided services similar to the proposed service and who satisfy at appraisal and revalidation that they have such continuing medical experience, training and competence as is necessary to enable them to contract for the enhanced service shall be deemed professionally qualified to do so.

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE 1.0 ACTION BY AWMSG: The All Wales Medicines Strategy Group (AWMSG) meeting held on 15 th December 2010 considered and approved the recommendations

More information

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( ) Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted

More information

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

Initiation of Warfarin for patients not registered with Provider Practice

Initiation of Warfarin for patients not registered with Provider Practice Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin

More information

Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session Date of Meeting: 22 March 2016 For: Decision Discussion Noting

Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session Date of Meeting: 22 March 2016 For: Decision Discussion Noting Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session Date of Meeting: 22 March 2016 For: Decision Discussion Noting PRIVATE session Agenda Item and title: Author: Lead Director/GP

More information

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and

More information

Quality Standards for Enhanced Primary Care Services. Version 1.2

Quality Standards for Enhanced Primary Care Services. Version 1.2 Quality Standards for Enhanced Primary Care Services Version 1.2 September 2014 8831 September 2014 West Midlands Quality Review Service These Quality Standards may be reproduced and used freely by NHS

More information

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9 Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services

More information

This SLA covers an enhanced service for care homes for older people and not any other care category of home.

This SLA covers an enhanced service for care homes for older people and not any other care category of home. Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service

More information

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 1 Enhanced service specification Avoiding unplanned admissions: proactive case

More information

Crawley CCG LCS Dec 15 Final

Crawley CCG LCS Dec 15 Final Crawley CCG LCS Dec 15 Final Crawley CCG Service Proposal for the inclusion of administration and monitoring of Denosumab 60mg Injection (Prolia )in GP Practices under a Locally Commissioned Service February

More information

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17

Enhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17 Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17 NHS England INFORMATION READER BOX Directorate Medical Commissioning

More information

Commissioning Policy

Commissioning Policy Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

3. The requirements for taking part in the ES are as follows:

3. The requirements for taking part in the ES are as follows: Enhanced Service Specification Learning disabilities health check scheme Background and purpose 1. This enhanced service (ES) is designed to encourage practices to identify all patients aged 14 and over

More information

GMS Contract in Wales Enhanced Service for Care Homes Specification

GMS Contract in Wales Enhanced Service for Care Homes Specification GMS Contract in Wales 2008-09 Enhanced Service for Care Homes Specification Doc 5 1. Introduction Many older people enter care homes to receive supportive care and these populations have increasing dependency

More information

National Enhanced Service (NES) for Intra-uterine contraceptive device fittings and contraceptive implants

National Enhanced Service (NES) for Intra-uterine contraceptive device fittings and contraceptive implants National Enhanced Service (NES) for Intra-uterine contraceptive device fittings and contraceptive implants Service Level Agreement PRACTICE Contents: 1. Finance Details 2. Signature Sheet 3. Service Aims

More information

Schedule C1. Community Pharmacy Anti-Coagulation Management Services

Schedule C1. Community Pharmacy Anti-Coagulation Management Services Schedule C1 Community Pharmacy Anti-Coagulation Management Services 1. Definition This service specification relates to the anticoagulation management of Service Users on warfarin by an accredited community

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Update on co-commissioning of primary care: guidance for CCG member practices and LMCs

Update on co-commissioning of primary care: guidance for CCG member practices and LMCs Update on co-commissioning of primary care: guidance for CCG member practices and LMCs British Medical Association bma.org.uk This paper is an update of previous GPC (general practitioners committee) guidance

More information

NHS 111 Clinical Governance Information Pack

NHS 111 Clinical Governance Information Pack NHS 111 Clinical Governance Information Pack This pack is designed to help you develop your local NHS 111 clinical governance framework and explain how it fits in to the wider context. It takes you through

More information

Ready for revalidation. Supporting information for appraisal and revalidation

Ready for revalidation. Supporting information for appraisal and revalidation 2012 Ready for revalidation Supporting information for appraisal and revalidation During their annual appraisals, doctors will use supporting information to demonstrate that they are continuing to meet

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

Mental Health (Wales) Measure Implementing the Mental Health (Wales) Measure Guidance for Local Health Boards and Local Authorities

Mental Health (Wales) Measure Implementing the Mental Health (Wales) Measure Guidance for Local Health Boards and Local Authorities Mental Health (Wales) Measure 2010 Implementing the Mental Health (Wales) Measure 2010 Guidance for Local Health Boards and Local Authorities Januar y 2011 Crown copyright 2011 WAG 10-11316 F6651011 Implementing

More information

How NICE clinical guidelines are developed

How NICE clinical guidelines are developed Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition

More information

SERVICE SPECIFICATION FOR THE PROVISION OF LONG-ACTING REVERSIBLE CONTRACEPTION SUB-DERMAL CONTRACEPTIVE IMPLANTS IN BOURNEMOUTH, DORSET AND POOLE

SERVICE SPECIFICATION FOR THE PROVISION OF LONG-ACTING REVERSIBLE CONTRACEPTION SUB-DERMAL CONTRACEPTIVE IMPLANTS IN BOURNEMOUTH, DORSET AND POOLE Revised for: 1 April 2015 Updated: 16 April 2015 Appendix 2.2 SERVICE SPECIFICATION FOR THE PROVISION OF LONG-ACTING REVERSIBLE CONTRACEPTION SUB-DERMAL CONTRACEPTIVE IMPLANTS IN BOURNEMOUTH, DORSET AND

More information

Pre-registration. e-portfolio

Pre-registration. e-portfolio Pre-registration e-portfolio 2013 2014 Contents E-portfolio Introduction 3 Performance Standards 5 Page Appendix SWOT analysis 1 Start of training plan 2 13 week plan 3 26 week plan 4 39 week plan 5 Appraisal

More information

Improving compliance with oral methotrexate guidelines. Action for the NHS

Improving compliance with oral methotrexate guidelines. Action for the NHS Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication

More information

Putting Barnsley People First. Quality and Patient Safety Committee Terms of Reference

Putting Barnsley People First. Quality and Patient Safety Committee Terms of Reference Putting Barnsley People First Quality and Patient Safety Committee Terms of Reference 1. Introduction NHS Barnsley Clinical Commissioning Group Quality and Patient Safety Committee 1.1 The Clinical Commissioning

More information

PATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE

PATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE PATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE Page 1 DOCUMENT CONTROL SHEET Name of Document: Patient Safety and Quality Committee Terms of Reference Version: 5 File Location / Document Name:

More information

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing

More information

REQUIREMENT. Identify a minimum of 4 theme areas which are considered to have caused concern for patients during 2012/13

REQUIREMENT. Identify a minimum of 4 theme areas which are considered to have caused concern for patients during 2012/13 2012/13 SSOTP CQUIN INDICATOR TARGETS INDICATOR REQUIREMENT 1. Patient Experience Milestone 1 (15th working day of April 2012) Identify a minimum of 4 theme areas which are considered to have caused concern

More information

The Mental Health (Wales) Measure Part 1 Scheme. Local Primary Mental Health Support Services. for

The Mental Health (Wales) Measure Part 1 Scheme. Local Primary Mental Health Support Services. for The Mental Health (Wales) Measure 2010 Part 1 Scheme Local Primary Mental Health Support Services for BETSI CADWALADR UNIVERSITY HEALTH BOARD ANGLESEY COUNTY COUNCIL GWYNEDD COUNCIL CONWY COUNTY BOROUGH

More information

Implementation of the right to access services within maximum waiting times

Implementation of the right to access services within maximum waiting times Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce

More information

BOARD PAPER - NHS ENGLAND. Internal Delegation arrangements for Greater Manchester Devolution

BOARD PAPER - NHS ENGLAND. Internal Delegation arrangements for Greater Manchester Devolution Paper: PB.31.03.16/08 BOARD PAPER - NHS ENGLAND Title: Internal Delegation arrangements for Greater Manchester Devolution Lead Director: Paul Baumann, Chief Financial Officer Karen Wheeler, National Director:

More information

A. Commissioning for Quality and Innovation (CQUIN)

A. Commissioning for Quality and Innovation (CQUIN) A. Commissioning for Quality and Innovation (CQUIN) CQUIN Table 1: Summary of goals Total fund available: 3,039,000 (estimated, based on 2015/16 baseline) Goal Number 1 2 3 4 5 Goal Name Description of

More information

NICE Charter Who we are and what we do

NICE Charter Who we are and what we do NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and

More information

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion. THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines

More information

Quality Accounts: Corroborative Statements from Commissioning Groups. Nottingham NHS Treatment Centre - Corroborative Statement

Quality Accounts: Corroborative Statements from Commissioning Groups. Nottingham NHS Treatment Centre - Corroborative Statement Quality Accounts: Corroborative Statements from Commissioning Groups Quality Accounts are annual reports to the public from providers of NHS healthcare about the quality of services they deliver. The primary

More information

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1 FORUM FOR EXCHANGE OF INFORMATION ON ENFORCEMENT Adopted at the 9 th meeting of the Forum on 1-3 March 2011 MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1 MARCH 2011 1 First edition adopted at the 6

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information

Author: Kelvin Grabham, Associate Director of Performance & Information

Author: Kelvin Grabham, Associate Director of Performance & Information Trust Policy Title: Access Policy Author: Kelvin Grabham, Associate Director of Performance & Information Document Lead: Kelvin Grabham, Associate Director of Performance & Information Accepted by: RTT

More information

GOVERNING BODY REPORT

GOVERNING BODY REPORT GOVERNING BODY REPORT 1. Date of Governing Body Meeting 16 th November 2017 2. Title of Report: 3. Key Messages: BUPA ceased to be the registered provider of Crawfords Walk Nursing Home in October. The

More information

NLC in Rheumatology: service setup, practical issues, quality assurance and auditing

NLC in Rheumatology: service setup, practical issues, quality assurance and auditing NLC in Rheumatology: service setup, practical issues, quality assurance and auditing Tricia Cornell Rheumatology Consultant Nurse Abbvie Honorary Senior Rheumatology Practitioner Poole Hospital NHS Foundation

More information

Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services

Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Reference No: Version: 1 Author: Emma Baggaley First Issued On: 1 st March 2018 Latest

More information

Any Qualified Provider: your questions answered

Any Qualified Provider: your questions answered Any Qualified Provider: your questions answered September 8, 2011 These answers cover a range of questions about the detail of Any Qualified Provider on integrated care, competition and procurement, liability

More information

GOVERNING BODY REPORT

GOVERNING BODY REPORT GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Finance, Performance and Commissioning Committee Report 3. Key Messages: At the end of March 2017 the clinical commissioning

More information

Consultation Group: See relevant page in the PGD. Review Date: October 2015

Consultation Group: See relevant page in the PGD. Review Date: October 2015 Patient Group Direction For The Supply Of Trimethoprim For The Treatment Of Women With Uncomplicated Urinary Tract Infections By Nurses And Pharmacists Working Within NHS Grampian Community Pharmacies

More information

Revalidation Annual Report

Revalidation Annual Report Paper 31 14 Revalidation Annual Report 2013-14 Purpose of Document: To provide the Board with a report on the first year s experience with medical revalidation in Public Health Wales. Board/Committee to-

More information

Review of Local Enhanced Services

Review of Local Enhanced Services Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Looked After Children Annual Report

Looked After Children Annual Report Looked After Children Annual Report Reporting period April 2016 March 2017 Authors Maxine Lomax - Designated Nurse for Child Protection & Looked After Children Dr. Bin Hooi Low - Designated Doctor for

More information

5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?

5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework? Item Number: 6.3 Governing Body Meeting: 4 February 2016 Report Sponsor Anthony Fitzgerald Director of Strategy and Delivery Report Author Anthony Fitzgerald Director of Strategy and Delivery 1. Title

More information

Local Enhanced Service Agreement 1 July March 2016

Local Enhanced Service Agreement 1 July March 2016 Local Enhanced Service Agreement 1 July 2013 31 March 2016 Recognition and Management of People with Dementia and their Family/Carers in General Practices in Bristol Agreement between NHS Bristol Clinical

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information

Coastal West Sussex Interface Prescribing Policy

Coastal West Sussex Interface Prescribing Policy Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex

More information

Personal Budgets and Direct Payments

Personal Budgets and Direct Payments Personal Budgets/Direct Payments Date of resource : April 20 Page 1 of Learning Aims The learning aims of this briefing are to enable you to 1 Understand how personal budgets can be requested for special

More information

CCG Policy for Working with the Pharmaceutical Industry

CCG Policy for Working with the Pharmaceutical Industry CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry

More information

NON-MEDICAL PRESCRIBING POLICY

NON-MEDICAL PRESCRIBING POLICY NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

The interface between primary and secondary care Key messages for NHS clinicians and managers

The interface between primary and secondary care Key messages for NHS clinicians and managers The interface between primary and secondary care Key messages for NHS clinicians and managers In partnership with: NHS England and NHS Improvement 2 Good organisation of care across the interface between

More information

Prime Ministers Challenge Fund

Prime Ministers Challenge Fund Prime Ministers Challenge Fund GP Recruitment - Information Pack GDoc Ltd Eastgate House, 121-131 Eastgate Street, Gloucester, GL1 1PX www.gdoc.org.uk Contents The Opportunity and Introduction 1 Background

More information

Service Specification

Service Specification Service Specification Minor Injuries Release: FINAL Date: 30/11/10 Author: Laura Smith Urgent Care Commissioning Manager NHS Derbyshire County Owner: Service Specification owner Owner s designation Owner

More information

Document Details. notification of entry onto webpage

Document Details.  notification of entry onto webpage Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As

More information

The Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts

The Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts The Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts Part A: Introduction Published by NHS England and NHS Improvement August 2017 First published: Friday

More information

WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0

WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review

More information

DEPARTMENT OF EDUCATION DEVELOPMENT PROPOSALS FOR GRANT-AIDED SCHOOLS

DEPARTMENT OF EDUCATION DEVELOPMENT PROPOSALS FOR GRANT-AIDED SCHOOLS DEPARTMENT OF EDUCATION DEVELOPMENT PROPOSALS FOR GRANT-AIDED SCHOOLS 2003 CONTENTS Page Introduction Consultation Format and content of Development Proposals Timing of Publication of Proposals Modification

More information

Shared Care Agreements for Medicines

Shared Care Agreements for Medicines Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:

More information

WOLVERHAMPTON CCG Commissioning Committee Wednesday 28 th September 2016

WOLVERHAMPTON CCG Commissioning Committee Wednesday 28 th September 2016 WOLVERHAMPTON CCG Wednesday Title of Report: Report of: Contact: Social Prescribing Proposal Andrea Smith Andrea Smith Action Required: Decision Assurance Purpose of Report: Public or Private: To present

More information

Registration and Inspection Service

Registration and Inspection Service Registration and Inspection Service Children s Residential Centre Centre ID number: 020 Year: 2017 Lead inspector: Michael McGuigan Registration and Inspection Services Tusla - Child and Family Agency

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures

More information

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019 Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history

More information

Committee is requested to action as follows: Richard Walker. Dylan Williams

Committee is requested to action as follows: Richard Walker. Dylan Williams BetsiCadwaladrUniversityHealthBoard Committee Paper 17.11.14 Item IG14_60 NameofCommittee: Subject: Summary or IssuesofSignificance StrategicTheme/Priority / Valuesaddressedbythispaper Information Governance

More information

Investment Committee: Extended Hours Business Case (Revised)

Investment Committee: Extended Hours Business Case (Revised) PAPER 06 Investment Committee: Extended Hours Business Case (Revised) OVERALL STRATEGY 1. SaHF Care Closer to Home This Extended Hours Business Case is developed within the context of Shaping a Healthier

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

Shared-care arrangements and the primary/secondary-care interface

Shared-care arrangements and the primary/secondary-care interface Shared-care arrangements and the primary/secondary-care interface Jas Khambh MRPharmS, DipPrescSci and Christian Barnick FRCOG Specialist and high-risk drugs are increasingly being prescribed in the community

More information

MENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS. Service Specification

MENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS. Service Specification MENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS Service Specification National Enhanced Service Specification for Meningococcal Serogroup B (MenB) Vaccination Programme. Introduction 1. This programme

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

Manis Aged Care Limited

Manis Aged Care Limited Manis Aged Care Limited Introduction This report records the results of a Surveillance Audit of a provider of aged residential care services against the Health and Disability Services Standards (NZS8134.1:2008;

More information

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

Job Description. 65,000 to 80,000 per annum based on qualifications, skills and experience

Job Description. 65,000 to 80,000 per annum based on qualifications, skills and experience Job Description Service Job Title Hours Salary Reports to Purpose of Job Specialty Doctor 37.5 hours per week 65,000 to 80,000 per annum based on qualifications, skills and experience Consultant Psychiatrist

More information

JOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area

JOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area JOB DESCRIPTION JOB TITLE: LOCATION: ACCOUNTABLE TO: RESPONSIBLE TO: PROFESSIONALLY RESPONSIBLE TO: LEAD PRACTICE BASED PHARMACIST Designated GP Practice in Federation area Federation Chair Practice Prescribing

More information

PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS

PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS Policy Details NHFT document reference MMPr030 Version 22/02/16 Date Ratified May 2016

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on

More information

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with

More information

Staffing Regulations for Aged Residential Care Facilities Consultation Document

Staffing Regulations for Aged Residential Care Facilities Consultation Document Staffing Regulations for Aged Residential Care Facilities Consultation Document Published in November 2004 by the Ministry of Health PO Box 5013, Wellington, New Zealand ISBN 0-478-25764-3 (Internet) HP

More information

Unlicensed Medicines Policy Document

Unlicensed Medicines Policy Document Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

SystmOne COMMUNITY OPERATIONAL GUIDELINES

SystmOne COMMUNITY OPERATIONAL GUIDELINES SystmOne COMMUNITY OPERATIONAL GUIDELINES Guidelines IM&T 11 Date: August 2007 Document Management Title of document SystmOne Community Operational Guidelines Type of document Guidelines IM&T 11 Description

More information

Quality Assurance Framework Adults Services. Framework. Version: 1.2 Effective from: August 2016 Review date: June 2017

Quality Assurance Framework Adults Services. Framework. Version: 1.2 Effective from: August 2016 Review date: June 2017 Quality Assurance Framework Adults Services Framework Version: 1.2 Effective from: August 2016 Review date: June 2017 Signed off by: Sharon Gogan Title: Head of Adult Social Care Date: 20 th May 2014 Quality

More information

NHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence

NHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development

More information

Quality and Governance Committee. Terms of Reference

Quality and Governance Committee. Terms of Reference Quality and Governance Committee Terms of Reference 1. Constitution 1.1 The Clinical Commissioning Group s Governing Body hereby resolves to establish a Committee of the Governing Body known as the Quality

More information

Primary Care Quality (PCQ) National Priorities for General Practice

Primary Care Quality (PCQ) National Priorities for General Practice Primary Care Quality (PCQ) National Priorities for General Practice Cluster Guidance and Templates 2015/16 Authors: Primary Care Quality Team Date: November 2015 Publication/ Distribution: Version: Final

More information

Delegated Commissioning of Primary Medical Services Briefing Paper

Delegated Commissioning of Primary Medical Services Briefing Paper Appendix One Delegated Commissioning of Primary Medical Services Briefing Paper 1.0 Introduction Swindon CCG has been jointly commissioning Primary Medical Services with NHS England under co-commissioning

More information

Sharing Healthcare Records

Sharing Healthcare Records On behalf of: NHS Leeds North Clinical Commissioning Group NHS Leeds South and East Clinical Commissioning Group NHS Leeds West Clinical Commissioning Group Sharing Healthcare Records An overview of healthcare

More information

COMMUNITY DEVELOPMENT AND SUPPORT EXPENDITURE SCHEME GUIDELINES

COMMUNITY DEVELOPMENT AND SUPPORT EXPENDITURE SCHEME GUIDELINES COMMUNITY DEVELOPMENT AND SUPPORT EXPENDITURE SCHEME GUIDELINES November 2009 Gaming Machine Tax Act 2001 First published October 2007 Revised July 2008 Revised February 2009 Revised November 2009 CONTENTS

More information

PGDs are permitted for use only by registered health professionals (see enclosed link for full list

PGDs are permitted for use only by registered health professionals (see enclosed link for full list NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred

More information

Patient Survey Analysis and Action Plan - 15 th January 2014

Patient Survey Analysis and Action Plan - 15 th January 2014 Patient Survey Analysis and Action Plan - 15 th January Key Areas Comments and Actions Action for Extended Hours 90% said current provision is convenient Those who didn t agree said extended hours appointments

More information

Overview of the TOUCH Program

Overview of the TOUCH Program Overview of the TOUCH Program Please see accompanying full Prescribing Information, including Boxed Warning. INDICATIONS AND USAGE Multiple Sclerosis (MS) TYSABRI (natalizumab) is indicated as monotherapy

More information